Skip to main content

Market Overview

Recap: Dynatronics Q1 Earnings

Share:

 

Shares of Dynatronics (NASDAQ:DYNT) fell 1.5% in pre-market trading after the company reported Q1 results.

Quarterly Results

Earnings per share fell 300.00% year over year to ($0.04), which beat the estimate of ($0.12).

Revenue of $12,133,000 decreased by 25.97% year over year, which beat the estimate of $10,550,000.

Guidance

Earnings guidance hasn't been issued by the company for now.

Dynatronics hasn't issued any revenue guidance for the time being.

Details Of The Call

Date: Nov 12, 2020

Time: 08:30 AM

ET Webcast URL: https://irdirect.net/DYNT/corporate_document/1982

Price Action

Company's 52-week high was at $3.70

Company's 52-week low was at $0.52

Price action over last quarter: down 21.61%

Company Overview

Dynatronics Corp is a United States-based company that is engaged in designing, manufacturing, and distributing advanced-technology medical devices, therapeutic and medical treatment tables, rehabilitation equipment, custom athletic training treatment tables and equipment, institutional cabinetry as well as other rehabilitation and therapy products and supplies. The company markets and sells its products to physical therapists, chiropractors, athletic trainers, sports medicine practitioners, and other medical professionals and institutions. It offers customers a one-stop-shop for their medical equipment and supply needs, including electrotherapy, therapeutic ultrasound, phototherapy, rehabilitation products, treatment tables, customized training room products, and exercise products.

 

Related Articles (DYNT)

View Comments and Join the Discussion!

Posted-In: Earnings News

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com